Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Charisse Somers"'
Autor:
Joery Goossens, Maria Bjerke, Hanne Struyfs, Ellis Niemantsverdriet, Charisse Somers, Tobi Van den Bossche, Sara Van Mossevelde, Bart De Vil, Anne Sieben, Jean-Jacques Martin, Patrick Cras, Johan Goeman, Peter Paul De Deyn, Christine Van Broeckhoven, Julie van der Zee, Sebastiaan Engelborghs
Publikováno v:
Alzheimer’s Research & Therapy, Vol 9, Iss 1, Pp 1-7 (2017)
Abstract Background The Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarkers Aβ1–42, t-tau, and p-tau181 overlap with other diseases. New tau modifications or epitopes, such as the non-phosphorylated tau fraction (p-taurel), may improve
Externí odkaz:
https://doaj.org/article/739dc84822e24a58a0682c69e1703657
Autor:
Julie Ottoy, Ellis Niemantsverdriet, Jeroen Verhaeghe, Ellen De Roeck, Hanne Struyfs, Charisse Somers, Leonie wyffels, Sarah Ceyssens, Sara Van Mossevelde, Tobi Van den Bossche, Christine Van Broeckhoven, Annemie Ribbens, Maria Bjerke, Sigrid Stroobants, Sebastiaan Engelborghs, Steven Staelens
Publikováno v:
NeuroImage: Clinical, Vol 22, Iss , Pp - (2019)
Disease-modifying treatment trials are increasingly advanced to the prodromal or preclinical phase of Alzheimer's disease (AD), and inclusion criteria are based on biomarkers rather than clinical symptoms. Therefore, it is of great interest to determ
Externí odkaz:
https://doaj.org/article/dc67dea772274a9e8d057102de46938e
Autor:
Claire Bridel, Charisse Somers, Anne Sieben, Annemieke Rozemuller, Ellis Niemantsverdriet, Hanne Struyfs, Yannick Vermeiren, Christine Van Broeckhoven, Peter P De Deyn, Maria Bjerke, Guy Nagels, Charlotte E Teunissen, Sebastiaan Engelborghs
Publikováno v:
Brain, 145(11), 4056-4064
Bridel, C, Somers, C, Sieben, A, Rozemuller, A, Niemantsverdriet, E, Struyfs, H, Vermeiren, Y, van Broeckhoven, C, de Deyn, P P, Bjerke, M, Nagels, G, Teunissen, C E & Engelborghs, S 2022, ' Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers ', Brain, vol. 145, no. 11, pp. 4056-4064 . https://doi.org/10.1093/brain/awac013
Brain 145 (2022) 11
Brain
Brain, 145(11), 4056-4064. Oxford University Press
Bridel, C, Somers, C, Sieben, A, Rozemuller, A, Niemantsverdriet, E, Struyfs, H, Vermeiren, Y, van Broeckhoven, C, de Deyn, P P, Bjerke, M, Nagels, G, Teunissen, C E & Engelborghs, S 2022, ' Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers ', Brain, vol. 145, no. 11, pp. 4056-4064 . https://doi.org/10.1093/brain/awac013
Brain 145 (2022) 11
Brain
Brain, 145(11), 4056-4064. Oxford University Press
Alzheimer’s disease CSF biomarkers 42 amino acid long amyloid-β peptide (Aβ1–42), total tau protein (T-tau), and tau protein phosphorylated at threonine 181 (P-tau181) are considered surrogate biomarkers of Alzheimer’s disease pathology, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f501ba25c6f76ce875ea1b82c799ac9
https://doi.org/10.1093/brain/awac013
https://doi.org/10.1093/brain/awac013
Autor:
Charlotte E. Teunissen, Jean-Jacques Martin, Maarten Timmers, Patrick Cras, Yannick Vermeiren, Naomi De Roeck, Anne Sieben, Maria Bjerke, Charisse Somers, Christine Van Broeckhoven, Bart De Vil, Peter Paul De Deyn, Sebastiaan Engelborghs, Eline A.J. Willemse
Publikováno v:
Willemse, E A J, Sieben, A, Somers, C, Vermeiren, Y, de Roeck, N, Timmers, M, van Broeckhoven, C, de Vil, B, Cras, P, de Deyn, P P, Martin, J-J, Teunissen, C E, Engelborghs, S & Bjerke, M 2021, ' Neurogranin as biomarker in CSF is non-specific to Alzheimer's disease dementia ', Neurobiology of Aging, vol. 108, pp. 99-109 . https://doi.org/10.1016/j.neurobiolaging.2021.08.002
Neurobiology of aging
Neurobiology of Aging, 108, 99-109. Elsevier Inc.
Neurobiology of aging 108 (2021)
Neurobiology of aging, 108, 99-109
Neurobiology of aging
Neurobiology of Aging, 108, 99-109. Elsevier Inc.
Neurobiology of aging 108 (2021)
Neurobiology of aging, 108, 99-109
We aimed to evaluate the specificity of neurogranin (Ng) for Alzheimer's disease (AD) in a dementia cohort. Cerebrospinal fluid (CSF) Ng was measured (ELISA) in two independent cohorts: (1) clinical (n = 116; age 72±11 years): AD, non-AD (+high T-ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a368df0a6a0f9d59c5492515949b994
https://research.vumc.nl/en/publications/7401124c-d959-45c0-a55b-156eb7648d89
https://research.vumc.nl/en/publications/7401124c-d959-45c0-a55b-156eb7648d89
Autor:
Charisse Somers, Christine Van Broeckhoven, Anne Sieben, Sebastiaan Engelborghs, Maria Bjerke, Johannes Kornhuber, Peter Paul De Deyn, Piotr Lewczuk, Jean-Jacques Martin
Publikováno v:
Journal of Alzheimer's Disease
Journal of Alzheimer's disease
Journal of Alzheimer's disease
Background: Despite decades of research on the optimization of the diagnosis of Alzheimer’s disease (AD), its biomarker-based diagnosis is being hampered by the lack of comparability of raw biomarker data. In order to overcome this limitation, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cfc8db1f97f34f28a958ea2ae7db684
https://doi.org/10.3233/jad-180563
https://doi.org/10.3233/jad-180563
Autor:
Sara Van Mossevelde, Leonie Wyffels, Charisse Somers, Sebastiaan Engelborghs, Jeroen Verhaeghe, Ellen De Roeck, Julie Ottoy, Tobi Van den Bossche, Maria Bjerke, Sarah Ceyssens, Ellis Niemantsverdriet, Sigrid Stroobants, Steven Staelens, Hanne Struyfs, Annemie Ribbens, Christine Van Broeckhoven
Publikováno v:
NeuroImage: Clinical
NeuroImage : Clinical
NeuroImage: Clinical, Vol 22, Iss, Pp-(2019)
NeuroImage : Clinical
NeuroImage: Clinical, Vol 22, Iss, Pp-(2019)
Disease-modifying treatment trials are increasingly advanced to the prodromal or preclinical phase of Alzheimer's disease (AD), and inclusion criteria are based on biomarkers rather than clinical symptoms. Therefore, it is of great interest to determ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec0a05356b68fc974aae226f6f647f56
https://repository.uantwerpen.be/docman/irua/a436aa/158295.pdf
https://repository.uantwerpen.be/docman/irua/a436aa/158295.pdf
Autor:
Peter Paul De Deyn, Naomi De Roeck, Charlotte E. Teunissen, Eline A.J. Willemse, Christine Van Broeckhoven, Patrick Cras, Jean-Jacques Martin, Yannick Vermeiren, Jill Luyckx, Sebastiaan Engelborghs, Bart De Vil, Charisse Somers, Maria Bjerke, Anne Sieben
Publikováno v:
Alzheimer's & Dementia. 14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::981253c81bd212ae42b6fb003e6d9351
https://doi.org/10.1016/j.jalz.2018.07.092
https://doi.org/10.1016/j.jalz.2018.07.092
Autor:
Anne Sieben, Naomi De Roeck, Hanne Struyfs, Sebastiaan Engelborghs, Peter Paul De Deyn, Maarten Timmers, Yannick Vermeiren, Hugo Vanderstichele, Charisse Somers, Hermien Acx, Britta Brix, Victor Herbst, Christine Van Broeckhoven, Maria Bjerke, Ellis Niemantsverdriet, Jean-Jacques Martin
Publikováno v:
Alzheimer's & Dementia. 15:P327-P328
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9deb5ba173c68a2b9284fddf19af8dd9
https://doi.org/10.1016/j.jalz.2019.06.792
https://doi.org/10.1016/j.jalz.2019.06.792
Autor:
Tobi Van den Bossche, Steven Deleye, Sigrid Stroobants, Steven Staelens, Sara Van Mossevelde, Sebastiaan Engelborghs, Hanne Struyfs, Julie Ottoy, Jeroen Verhaeghe, Charisse Somers, Sarah Ceyssens, Femke Soetewey, Jan Versijpt, Ellen Elisa De Roeck, Ellis Niemantsverdriet, Leonie Wyffels
Publikováno v:
The Journal of nuclear medicine
Increased brain uptake of [18F]-AV45 visualized by PET is a key biomarker for Alzheimers disease (AD). The standardized uptake value ratio (SUVR) is widely used for quantification, but is subject to variability based on choice of reference region and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2634bf2f44daa4cd28bd2c4ac8b6f18
https://biblio.vub.ac.be/vubir/validation-of-the-semiquantitative-static-suvr-method-for-f18av45-pet-by-pharmacokinetic-modeling-with-an-arterial-input-function(ef0f042a-e9bd-4e9f-8aec-baebced5abec).html
https://biblio.vub.ac.be/vubir/validation-of-the-semiquantitative-static-suvr-method-for-f18av45-pet-by-pharmacokinetic-modeling-with-an-arterial-input-function(ef0f042a-e9bd-4e9f-8aec-baebced5abec).html
Autor:
Tobi Van den Bossche, Jeroen Verhaeghe, Christine Van Broeckhoven, Sara Van Mossevelde, Julie Ottoy, Peter Mariën, Sebastiaan Engelborghs, Peter Paul De Deyn, Jan Versijpt, Femke Soetewey, Johan Goeman, Steven Staelens, Sigrid Stroobants, Ellen De Roeck, Sarah Ceyssens, Adrien Albert, Hanne Struyfs, Leonie Wyffels, Ellis Niemantsverdriet, Maria Bjerke, Kristel Sleegers, Charisse Somers
Publikováno v:
Journal of Alzheimer's Disease
Journal of Alzheimer's disease
Journal of Alzheimer's disease
Background: Evidence suggests that the concordance between amyloid-PET and cerebrospinal fluid (CSF) amyloid-beta (A beta) increases when the CSF A beta(1-42)/A beta(1-40) ratio is used as compared to CSF A beta(1-42) levels alone. Objective: In orde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd0b919c57268610614a05ee3094d76f
https://doi.org/10.3233/jad-170327
https://doi.org/10.3233/jad-170327